# Monomorphic T-cell post-transplant lymphoproliferative disorder with features of HHV8-negative primary effusion lymphoma: an autopsy case and review of the literature

**Authors:** Naoki Hosaka, Mitsuharu Hashimura, Atsuko Mugitani, Masanari Hamaguchi, Yuki Kubo, Shin-ichi Nakatsuka

PMC · DOI: 10.1007/s00795-024-00388-x · Medical Molecular Morphology · 2024-05-23

## TL;DR

A rare T-cell lymphoma resembling HHV8-negative primary effusion lymphoma was identified in a post-transplant patient, suggesting a possible link to early renal transplantation.

## Contribution

Identification of a novel monomorphic T-cell post-transplant lymphoproliferative disorder resembling HHV8-negative primary effusion lymphoma.

## Key findings

- The case showed CD3, CD4, and CD30 positivity but lacked CD8, CD20, and viral markers.
- Chromosomal aberrations and T-cell receptor gene rearrangements were observed.
- Literature review identified six T-cell effusion lymphoma cases, half with a history of renal transplantation in their twenties.

## Abstract

A 67-year-old man underwent renal transplantation in his twenties. He developed refractory pleural effusion, with many large lymphocytes with severe atypia and mitosis in the effusion, indicating malignant lymphoma. He finally died of respiratory failure. An autopsy revealed atypical lymphocytes positive for CD3, CD4, and CD30 and negative for CD8, CD20, PAX5, human herpesvirus (HHV) 8, and Epstein–Barr virus-encoded small RNAs by immunohistochemistry and in situ hybridization. Atypical lymphocytes also had T-cell receptor gene rearrangements Jβ2, Jγ2, and Jδ1 and chromosomal aberrations der(8)t(1;8)(q21;p21), add(13)(q12), add(14)(q32), and add(16)(q12-13). A few atypical lymphocytes were present at other sites. We finally diagnosed this case as monomorphic T-cell post-transplant lymphoproliferative disorder with features of HHV8-negative primary effusion lymphoma. A literature review only identified six cases (four HHV8-negative, two HHV8-positive) of effusion lymphoma of T-cell type, including the present case. Interestingly, about half of HHV8-negative and HHV8-positive cases had a history of renal transplantation in their twenties. All cases showed tumor CD30 expression, whereas CD4 and CD8 expressions were inconsistent. These findings indicated that this lymphoma may be associated with post-transplant lymphoproliferative disorder by renal transplantation at a young age, although further cases need to be analyzed.

## Linked entities

- **Genes:** cd.3 (Cd.3 conserved hypothetical protein) [NCBI Gene 1258599], CD4 (CD4 molecule) [NCBI Gene 920], TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943], CD8A (CD8 subunit alpha) [NCBI Gene 925], MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931], PAX5 (paired box 5) [NCBI Gene 5079], LOC107825322 (lysophospholipid acyltransferase LPEAT2) [NCBI Gene 107825322]
- **Diseases:** post-transplant lymphoproliferative disorder (MONDO:0019088), primary effusion lymphoma (MONDO:0018842), respiratory failure (MONDO:0021113)

## Full-text entities

- **Genes:** PAX5 (paired box 5) [NCBI Gene 5079] {aka ALL3, BSAP, PAX-5}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TNFRSF8 (TNF receptor superfamily member 8) [NCBI Gene 943] {aka CD30, D1S166E, Ki-1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}
- **Diseases:** post-transplant lymphoproliferative disorder (MESH:D008232), respiratory failure (MESH:D012131), effusion lymphoma (MESH:D054685), tumor (MESH:D009369), effusion (MESH:D000080324), lymphoma (MESH:D008223), pleural effusion (MESH:D010996)
- **Species:** human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11343895/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11343895/full.md

---
Source: https://tomesphere.com/paper/PMC11343895